HCmed Innovations Co., Ltd. (TPEX:6934)
Taiwan · Delayed Price · Currency is TWD 148.50
+15.00 (11.24%)
At close: Jan 20, 2026
HCmed Innovations Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 122.94 | 141.61 | 9.24 | 6.48 | 54.06 | 32.32 | |
Revenue Growth (YoY) | 209.09% | 1433.43% | 42.56% | -88.02% | 67.23% | - |
Cost of Revenue | 58.3 | 41.96 | 35.38 | 37.25 | 19.41 | 36.15 |
Gross Profit | 64.64 | 99.65 | -26.15 | -30.77 | 34.65 | -3.83 |
Selling, General & Admin | 67.66 | 63.91 | 49.94 | 48.38 | 20.75 | 14.14 |
Research & Development | 68.29 | 73.34 | 67.67 | 66.85 | 43.31 | 36.64 |
Amortization of Goodwill & Intangibles | - | - | - | - | 11.45 | 11.93 |
Operating Expenses | 135.95 | 137.24 | 117.61 | 115.24 | 75.51 | 62.71 |
Operating Income | -71.31 | -37.59 | -143.76 | -146 | -40.87 | -66.54 |
Interest Expense | -1.01 | -0.24 | -0.29 | -0.06 | -0.05 | -0.04 |
Interest & Investment Income | 3.07 | 2.48 | 0.83 | 0.32 | 0.19 | 0.39 |
Earnings From Equity Investments | - | - | - | -0.19 | -1.57 | -0.14 |
Currency Exchange Gain (Loss) | 0.68 | 1.44 | 0.01 | 0.24 | -0.38 | -0.58 |
Other Non Operating Income (Expenses) | 0.05 | 0.05 | 0.15 | 0.04 | 0.06 | 0.03 |
EBT Excluding Unusual Items | -68.53 | -33.86 | -143.07 | -145.65 | -42.62 | -66.88 |
Impairment of Goodwill | -12.16 | -12.16 | -23.33 | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | 1.63 | - | - |
Asset Writedown | -16.77 | -4.91 | - | - | - | - |
Other Unusual Items | 0.02 | - | - | - | 2.43 | 5.31 |
Pretax Income | -97.43 | -50.93 | -166.4 | -144.03 | -40.19 | -61.56 |
Income Tax Expense | 25.02 | 27.29 | -0.47 | -0.24 | - | - |
Net Income | -122.45 | -78.21 | -165.93 | -143.79 | -40.19 | -61.56 |
Net Income to Common | -122.45 | -78.21 | -165.93 | -143.79 | -40.19 | -61.56 |
Shares Outstanding (Basic) | 31 | 30 | 27 | 22 | 18 | 17 |
Shares Outstanding (Diluted) | 31 | 30 | 27 | 22 | 18 | 17 |
Shares Change (YoY) | 6.80% | 13.06% | 23.01% | 23.04% | 0.63% | - |
EPS (Basic) | -3.89 | -2.60 | -6.25 | -6.66 | -2.29 | -3.53 |
EPS (Diluted) | -3.89 | -2.60 | -6.25 | -6.66 | -2.29 | -3.53 |
Free Cash Flow | -117.04 | -43.38 | -127.74 | -87.95 | -19.82 | -36.88 |
Free Cash Flow Per Share | -3.72 | -1.44 | -4.81 | -4.07 | -1.13 | -2.11 |
Gross Margin | 52.58% | 70.37% | -283.14% | - | 64.10% | -11.85% |
Operating Margin | -58.00% | -26.55% | -1556.70% | -2253.83% | -75.60% | -205.86% |
Profit Margin | -99.60% | -55.23% | -1796.71% | -2219.67% | -74.34% | -190.45% |
Free Cash Flow Margin | -95.20% | -30.63% | -1383.17% | -1357.64% | -36.67% | -114.08% |
EBITDA | -62.84 | -29.46 | -135.19 | -138.36 | -37.17 | -62.75 |
EBITDA Margin | -51.12% | -20.80% | - | - | -68.76% | -194.13% |
D&A For EBITDA | 8.46 | 8.13 | 8.57 | 7.64 | 3.7 | 3.79 |
EBIT | -71.31 | -37.59 | -143.76 | -146 | -40.87 | -66.54 |
EBIT Margin | -58.00% | -26.55% | - | - | -75.60% | -205.86% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.